000504 *ST南華生物
按盤價 
9.500 +0.040 (+0.423%)
9.500 +0.040 (+0.423%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.092 | 11.466 | -8.034 | -20.795 | -81.291 |
| 總資產報酬率 ROA (%) | 1.106 | 3.604 | -2.877 | -4.253 | -2.055 |
| 投入資產回報率 ROIC (%) | 1.341 | 4.572 | -4.413 | -8.426 | -6.075 | 邊際利潤分析 |
| 銷售毛利率 (%) | 20.462 | 22.070 | 67.416 | 68.063 | 64.792 |
| 營業利潤率 (%) | 9.730 | 4.820 | -15.481 | -33.419 | -13.052 |
| 息稅前利潤/營業總收入 (%) | 11.623 | 5.151 | -15.686 | -26.025 | -4.978 |
| 淨利潤/營業總收入 (%) | 9.284 | 4.340 | -17.795 | -34.198 | -14.704 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.631 | 64.456 | 16.196 | 46.053 | 32.101 |
| 價值變動淨收益/利潤總額(%) | 4.319 | 39.088 | -17.662 | -2.133 | 0.255 |
| 營業外收支淨額/利潤總額(%) | -0.530 | -1.649 | 0.180 | -2.246 | -21.290 | 償債能力分析 |
| 流動比率 (X) | 1.383 | 1.355 | 1.316 | 1.448 | 0.915 |
| 速動比率 (X) | 1.295 | 1.321 | 1.204 | 1.424 | 0.905 |
| 資產負債率 (%) | 63.689 | 63.951 | 53.632 | 60.503 | 85.509 |
| 帶息債務/全部投入資本 (%) | 62.344 | 62.946 | 44.276 | 40.105 | 85.157 |
| 股東權益/帶息債務 (%) | 52.836 | 51.823 | 119.935 | 141.467 | 7.621 |
| 股東權益/負債合計 (%) | 42.767 | 41.902 | 72.690 | 55.054 | 2.961 |
| 利息保障倍數 (X) | 5.979 | 12.581 | 88.422 | -3.907 | -0.861 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 144.389 | 154.971 | 351.848 | 371.056 | 318.839 |
| 存貨周轉天數 (天) | 31.870 | 29.278 | 183.743 | 62.467 | 38.635 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 11/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
